Stocks/GMAB

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

GMAB

ACCE Researched
Genmab A/S ADS
HealthcareBiotechnologyNASDAQ
$26.45
-0.26%today
MKT CAP
$16.2B
NEXT EARNINGS
May 7
Get the ACCE weekly digest
Index returns, picks recap, score movers — every Sunday. No fluff.